AKC top breeds list features longtime faves, two surprisesMarch 29, 2018The American Kennel Club (AKC) released its annual breed popularity rankings Wednesday, and unsurprisingly, the nation still loves its happy-go-lucky Labrador retrievers 27 years after their first appearance as top dog. German Shepherd dogs and golden retrievers remain in the AKC's No. 2 and No. 3 spots, respectively. What is surprising is the rise of French bulldogs to No. 4 from No. 76 in just 20 years. Bulldogs, beagles, poodles, Rottweilers, and Yorkshire terriers make up No. 5 through No. 9. The German shorthaired pointer made the No. 10 spot this year (a GSP won Westminster Kennel Club dog show in 2016). The dogs are cute, compact, and relatively quiet, making them a breed of choice for urbanites. But not everyone is excited about the French bulldog's rising popularity. However, they suffer from health issues common among brachycephalic breeds, as well as and spinal and eye problems, and are often born by cesarean section. Sometimes they require nasal or palate surgery. John de Jong, DVM, a Newton, Mass., veterinarian who is president-elect of the American Veterinary Medical Association said he acknowledges the breed's conditions and challenges, but added that other dogs face their own particular challenges. …
SPONSORED CONTENTA new way to offer multi-organ supportNEW Hill's Prescription Diet Multi-Organ offers therapeutic nutrition for pets that may have conflicting nutritional needs. + Learn More
Could noise sensitivity in dogs be a cry for pain relief?March 26, 2018 A study conducted by animal behavior scientists from the U.K. and Brazil found that dogs that show fear or anxiety when faced with loud or sudden noises could actually be in pain. The researchers examined cases of dogs that had developed sensitivity to variations in noise volume, pitch, and occurrence, and found they also had associated musculoskeletal pain. The undiagnosed pain could be exacerbated when auditory stimuli makes the dogs tense or jump, placing extra stress on muscles or joints that already are inflamed, causing further pain, according to the study. That pain is then associated with a loud or startling noise, leading to sensitivity to noise and avoidance of situations where they had a previous bad experience, such as at a local park or in a loud room at home. According to the researchers, veterinarians should give any dog with a behavior issue a thorough physical exam to determine that if pain is a factor, it can be diagnosed and treated, and the behavior issue can then be addressed. In the study, all dogs that experienced pain and were treated showed improvement in behavior. Pain, behavior issues, and the onset of pain "Although the average ages of the …
Dog flu goes viralMarch 13, 2018While it’s unknown how many dogs have been affected—canine influenza isn’t a reportable disease in the U.S., although it is in Canada—the figures are underreported, said Cynda Crawford, DVM, clinical assistant professor at the University of Florida College of Veterinary Medicine.
An inconvenient truthFebruary 16, 2018If you’re like me, you were raised to think that all dogs should be sterilized. Veterinary school and our lives in practice further reinforced that truism. Dogs, we were reverently informed, require sterilization if they’re to live long, healthy lives.
Raw feeding trends continue to rack up risks for dogsFebruary 8, 2018In a new study, researchers at the University of Melbourne's U-Vet Werribee Animal Hospital found that consuming raw chicken meat increases a dog's risk of developing acute polyradiculoneuritis (APN) by more than 70 times. The cause of APN in dogs has baffled the veterinary community for a long time, said Matthias le Chevoir, DVM, DECVN, chief investigator on the project. "It is a rare but very debilitating condition where the dog's hind legs first become weak," he said. "It can then progress to affect the front legs, neck, head and face. Some dogs may die from the disease if their chest becomes paralyzed. Most dogs eventually recover without treatment but it may take up to six months or more in some cases. "In our clinic alone we see around 30 cases per year and around three in ten cases would not recover," Dr. le Chevoir continued. "Watching your pet suffer is obviously very distressing and it can be difficult for owners to nurse their pet if the condition can gradually improve." Paralysis results from the dog's immune system becoming unregulated and attacking its own nerve roots, progressively worsening over several days. APN is the canine version …
Tell me about your puppyhood...February 2, 2018The Canine Science Collaboratory, located in the Department of Psychology at Arizona State University in Tempe, is on a unique mission: to better understand the behavior and cognition of dogs and their wild relatives. It’s an ambitious goal with tremendous implications for dogs, owners, veterinarians, and others who work with one of America’s most popular pets.
Elanco announces FDA approval of new flea, tick preventiveJanuary 24, 2018Elanco Animal Health, a division of Eli Lilly and Co., announced that Credelio has been approved by the FDA. Credelio is a new monthly oral tick and flea option for dogs that contains the patented active ingredient lotilaner, which targets the nervous system receptors of ticks and fleas, not dogs, according to the company. The preventive protects against lone star, American dog, black-legged, and brown dog ticks, as well as fleas. "When choosing pet medications, veterinarians and pet owners are most concerned with safety for the pet as well as efficacy of the product. Lotilaner, the active ingredient in Credelio, was selected from hundreds of candidate molecules with this in mind," said Tony Rumschlag, DVM, director, regional consulting for Elanco. "This new tasty chewable is fast-acting and effective against ticks and fleas, while being easy on dogs and puppies." In a field study, 100 percent of Credelio tablets were administered successfully and dogs accepted 94 percent of them when offered by hand, in an empty bowl, or with food, according to the company. The product's active ingredient—lotilaner—circulates in the dog's blood stream, targeting the receptors of ticks and fleas when they bite the dog. In clinical studies, it killed 100 …
Common and 'forgotten' head and neck lymphocentrumsJanuary 8, 2018Recently, a young Weimaraner presented for eyelid surgery through our ophthalmology department, and it was noticed that he had bilaterally symmetrical subcutaneous soft tissue swellings dorsal to the maxillary third premolar teeth.
ASU awarded $6.4M grant to test preventive canine cancer vaccineJanuary 8, 2018Arizona State University (ASU) professor Stephen Albert Johnson, Ph.D., has received a $6.4 million grant from the Open Philanthropy Project to support a clinical trial of a vaccine to prevent canine cancer. The trial will involve approximately 800 middle-aged, healthy pet dogs and will test the effects of a multivalent frameshift peptide (FSP) vaccine developed at ASU that has shown promise in mouse studies. Scientists think the vaccine has potential for human use, too. "Our goal has always been that if this is possible, we should at least try it," said Johnston, director of the Biodesign Center for Innovations in Medicine and CEO of Calviri Inc., a cancer vaccine company. "Open Philanthropy was the only organization that responded to support our high-risk project, the biggest cancer intervention trial in dogs ever." Johnston and his team developed the new FSP vaccine over the past 10 years. The vaccine, already tested for efficacy in mice, is shown to be safe in dogs, according to Johnston's research. Cancer is the leading cause of death in pet dogs and their cancers are very similar to their human counterparts. Some breeds have a very high cancer rate, as much as 40 percent. The canine …
Zomedica, Celsee Inc. partner to deliver cancer liquid biopsy platformDecember 21, 2017Zomedica Pharmaceuticals Corp. has entered into a license and supply agreement with Celsee Inc., an innovator of progressive rare cell capture, characterization, and retrieval products in the emerging field of liquid biopsy. Under the terms of the agreement, Zomedica will have animal health exclusive global rights to develop and market Celsee's liquid biopsy platform for use by veterinarians as a cancer diagnostic. A liquid biopsy is a blood test with the potential to detect the presence of circulating tumor cells in the blood. Circulating tumor cells (CTC) are shed from a primary tumor into neighboring blood vessels and are transported throughout the body's circulatory system. The detection of CTCs in the blood could indicate a cancer diagnosis without the need for an invasive tissue biopsy, according to Zomedica. "Liquid biopsy is cutting-edge technology in human medicine right now and we're excited about the opportunity to develop and market this platform for use in veterinary medicine," stated Gerald Solensky, Jr., CEO at Zomedica. "We selected the Celsee platform because of the ease of use, workflow simplicity, and flexibility to use our novel canine biomarkers. If we successfully develop Celsee's technology, we believe we will be able to …
